Palisade Bio (PALI) Other Non-Current Assets (2010 - 2026)

Palisade Bio's (PALI) quarterly Other Non-Current Assets came in at $17000.0 in Q1 2026, down 92.34% year-on-year from $222000.0 in Q1 2025, and down 69.09% on a QoQ basis from $55000.0 in Q4 2025.

Palisade Bio (PALI) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Palisade Bio (PALI) has 17 years of Other Non-Current Assets data on file, last reported at $17000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 92.34% year-over-year to $17000.0 in Q1 2026; TTM through Mar 2026 was $17000.0, a 92.34% decrease from a year earlier, with the FY2025 full-year figure at $55000.0, down 79.85% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $17000.0, down from $55000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PALI reached as high as $592000.0 in Q2 2023 and fell as low as $12000.0 in Q3 2022.
  • Historically, Other Non-Current Assets has averaged $150882.4 across 5 years, with a median of $26000.0 in 2022.
  • Across the five-year window, Other Non-Current Assets plunged 96.98% in 2022 and soared 3550.0% in 2023, its largest moves.
  • Year by year, Other Non-Current Assets stood at $26000.0 in 2022, then tumbled by 53.85% to $12000.0 in 2023, then soared by 2175.0% to $273000.0 in 2024, then slumped by 79.85% to $55000.0 in 2025, then slumped by 69.09% to $17000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $17000.0 in Q1 2026, $55000.0 in Q4 2025, and $119000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Palisade Bio 985.76 -132.63 Mn - 17,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 17,000.00
Dec 31, 2025 55,000.00
Sep 30, 2025 119,000.00
Jun 30, 2025 12,000.00
Mar 31, 2025 222,000.00
Dec 31, 2024 273,000.00
Sep 30, 2024 324,000.00
Jun 30, 2024 387,000.00
Mar 31, 2024 12,000.00
Dec 31, 2023 12,000.00
Sep 30, 2023 438,000.00
Jun 30, 2023 592,000.00
Mar 31, 2023 12,000.00
Dec 31, 2022 26,000.00
Sep 30, 2022 12,000.00
Jun 30, 2022 26,000.00
Mar 31, 2022 26,000.00
Dec 31, 2021 26,000.00
Sep 30, 2021 26,000.00
Jun 30, 2021 26,000.00